We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-14.12%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$64.1B
AUM Growth
-$17.5B
Cap. Flow
-$4.25B
Cap. Flow %
-6.62%
Top 10 Hldgs %
6.66%
Holding
4,541
New
702
Increased
1,343
Reduced
1,571
Closed
844

Top Sells

Rank Stock Value
1
FTV icon
Fortive
FTV
+$1.27B
2
ANDV
Andeavor
ANDV
+$1.11B
3
AET
Aetna Inc
AET
+$535M
4
MSFT icon
Microsoft
MSFT
+$350M
5
AMZN icon
Amazon
AMZN
+$290M

Sector Composition

Rank Sector Weight
1 Healthcare 13.69%
2 Technology 13.64%
3 Financials 12.49%
4 Consumer Discretionary 10.83%
5 Industrials 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOC icon
3801
Healthpeak Properties
DOC
$14.8B
-69,687
Closed -$1.83M
DRD
3802
DRDGold
DRD
$2.66B
-74,372
Closed -$180K
DSX icon
3803
Diana Shipping
DSX
$337M
-404,613
Closed -$1.17M
DUK icon
3804
Duke Energy
DUK
$93.4B
-720,892
Closed -$57.7M
DVA icon
3805
CALL
DaVita
DVA
$11.1B
-110,000
Closed -$7.88M
E icon
3806
ENI
E
$81.5B
-10,763
Closed -$405K
ECL icon
3807
Ecolab
ECL
$78.9B
-13,223
Closed -$2.07M
ECOR icon
3808
electroCore
ECOR
$94.8M
-1,510
Closed -$317K
ECVT icon
3809
Ecovyst
ECVT
$1.14B
-57,658
Closed -$1.01M
EDSA icon
3810
Edesa Biotech
EDSA
$42.7M
-403
Closed -$24K
EEMV icon
3811
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.6B
-9,797
Closed -$581K
EGO icon
3812
Eldorado Gold
EGO
$11.9B
-267,552
Closed -$1.18M
EIM
3813
Eaton Vance Municipal Bond Fund
EIM
$492M
-10,200
Closed -$118K
CHRN
3814
ChronoScale Holdings
CHRN
$3.46B
-253
Closed -$133K
ELAN icon
3815
Elanco Animal Health
ELAN
$12B
-382,067
Closed -$13.3M
ELMD icon
3816
Electromed
ELMD
$327M
-12,816
Closed -$83K
EMN icon
3817
PUT
Eastman Chemical
EMN
$8.47B
-35,700
Closed -$3.42M
ENVB icon
3818
Enveric Biosciences
ENVB
$6.4M
0
-$155K
EOLS icon
3819
Evolus
EOLS
$554M
-290,427
Closed -$5.41M
EOS
3820
Eaton Vance Enhance Equity Income Fund II
EOS
$1.14B
-17,876
Closed -$316K
EPAC icon
3821
Enerpac Tool Group
EPAC
$1.9B
-232,624
Closed -$6.49M
EPI icon
3822
WisdomTree India Earnings Fund ETF
EPI
$2.03B
-114,368
Closed -$2.76M
ERC
3823
Allspring Multi-Sector Income Fund
ERC
$261M
-17,174
Closed -$209K
EMBJ
3824
CALL
Embraer S.A. ADS
EMBJ
$13.5B
-138,000
Closed -$2.7M
ESI icon
3825
Element Solutions
ESI
$8.6B
-343,160
Closed -$4.28M

Similar funds

Israel Englander's Q4 2018 Portfolio in Review

As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.

  • Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
  • Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
  • Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
  • Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
  • Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
  • Israel Englander opened 702 new positions and closed 844 in Q4 2018.
  • Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.

Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.